Wound Care Laboratory Testing Requirements: Your Path to Compliance
About
Date/Time
July 11, 2024
- In vitro testing requirements, including the newly updated EN13726 standard
- Regulatory expectations, with a focus on regional wound care auditors’ requirements
- The importance of using appropriate test methods to support rapid product development and streamlined routes to regulatory approval
*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.
NAMSA uses a third-party provider, GoToWebinar, to host NAMSA webinars. For information related to GoToWebinar’s privacy policy and utilization of information, please contact GoToWebinar directly.
Speaker
Rachel Gibbs, BSc, PhD
Principal Regulatory ConsultantRachel Gibbs has 15 years’ experience in the medical device and pharmaceutical industries, and also as a Senior Auditor for a leading European Notified Body. Rachel joined NAMSA in 2021 and has used her knowledge of MDR auditing to advise Clients regarding regulatory and clinical strategies, undertaking Gaps Assessments and writing MDR submission documents.
Rachel started her career at the Medicines and Healthcare Products Regulatory Agency (MHRA) working on drug variation and renewal licensing before moving back into academia to conduct a PhD in Immunology. Thereafter, Rachel moved into the pharmaceutical industry, joining 3M Healthcare, working on the development of metered dose inhalers and nasal sprays for U.S. Food and Drug Administration (FDA) and EMEA drug applications. With the opening of 3M’s Skin and Wound Care Laboratory, she transitioned into the medical device industry and was actively involved in new product development for a range of wound care devices, inclusive of design control, risk management, manufacturing upscaling and process validation. Rachel then moved to BSI in 2015 as a Senior Auditor and Clinical Evaluation Specialist involved in product conformity assessment to the Medical Device Directive (93/42/EEC), and subsequently audited against the Medical Device Regulation ([EU] 2017/475).
Shazia A. Siddiqui, MS, NRCM
Principal MicrobiologistShazia A. Siddiqui has over 20 years of industry experience, with a focus on medical devices including Wound Care, Cardiovascular, Ophthalmology, and Dental areas. She joined NAMSA in 2010 as a Principal Microbiologist, where she plays a key role in developing and improving processes and testing services. Shazia provides technical support to various teams and R&D customers, as well as assistance with microbiological inquiries. With a Master’s degree in Genetics and a Bachelor’s degree in Microbiology, she is a certified Microbiologist and a subject matter expert in the custom microbiological lab at NAMSA. Shazia is an active member of ASTM and AATCC.